Â鶹ÊÓƵ

Does the sector offer value out of post-pandemic doldrums?

Politics is exasperating but investors can look after themselves

Finding quality compounders amid a fundamentally changed backdrop

Earnings growth forecasts must be balanced against valuation

Options for growth at a more reasonable price

In case trade headaches hit big dividend payers is it time to look at mid-caps?

Trade war should prompt reflection over which shares are quality compounders

Valuation risk remains key in volatile markets

Growth on a more reasonable price after recent selling

Are pay-outs on London’s junior market a bargain?